| __timestamp | Bristol-Myers Squibb Company | Vertex Pharmaceuticals Incorporated |
|---|---|---|
| Wednesday, January 1, 2014 | 11947000000 | 519428000 |
| Thursday, January 1, 2015 | 12651000000 | 906794000 |
| Friday, January 1, 2016 | 14481000000 | 1491717000 |
| Sunday, January 1, 2017 | 14710000000 | 2213533000 |
| Monday, January 1, 2018 | 16014000000 | 2638058000 |
| Tuesday, January 1, 2019 | 18067000000 | 3615063000 |
| Wednesday, January 1, 2020 | 30745000000 | 5469383000 |
| Friday, January 1, 2021 | 36445000000 | 6670200000 |
| Saturday, January 1, 2022 | 36022000000 | 7850400000 |
| Sunday, January 1, 2023 | 34313000000 | 8607000000 |
| Monday, January 1, 2024 | 36351000000 | 9489600000 |
Unleashing the power of data
In the ever-evolving landscape of the pharmaceutical industry, the financial health of companies is a key indicator of their market position and potential for innovation. Over the past decade, Bristol-Myers Squibb Company and Vertex Pharmaceuticals Incorporated have showcased contrasting trajectories in their gross profit trends.
From 2014 to 2023, Bristol-Myers Squibb's gross profit surged by nearly 187%, peaking in 2021. This growth reflects their strategic acquisitions and robust product pipeline. In contrast, Vertex Pharmaceuticals, while starting from a smaller base, demonstrated an impressive growth rate of over 1,500% during the same period, highlighting their focus on niche markets and breakthrough therapies.
These trends underscore the dynamic nature of the pharmaceutical sector, where strategic focus and innovation drive financial success. As we look to the future, these companies' ability to adapt and innovate will be crucial in maintaining their competitive edge.
Eli Lilly and Company and Bristol-Myers Squibb Company: A Detailed Gross Profit Analysis
Key Insights on Gross Profit: Novartis AG vs Vertex Pharmaceuticals Incorporated
Who Generates Higher Gross Profit? Bristol-Myers Squibb Company or BioMarin Pharmaceutical Inc.
Gross Profit Analysis: Comparing Bristol-Myers Squibb Company and MorphoSys AG
Gross Profit Comparison: Bristol-Myers Squibb Company and Ligand Pharmaceuticals Incorporated Trends
Vertex Pharmaceuticals Incorporated vs Regeneron Pharmaceuticals, Inc.: A Gross Profit Performance Breakdown
Vertex Pharmaceuticals Incorporated vs Teva Pharmaceutical Industries Limited: A Gross Profit Performance Breakdown
Key Insights on Gross Profit: Vertex Pharmaceuticals Incorporated vs United Therapeutics Corporation
Gross Profit Analysis: Comparing Vertex Pharmaceuticals Incorporated and Corcept Therapeutics Incorporated
Who Generates Higher Gross Profit? Vertex Pharmaceuticals Incorporated or Grifols, S.A.
Gross Profit Comparison: Vertex Pharmaceuticals Incorporated and Amneal Pharmaceuticals, Inc. Trends
Gross Profit Trends Compared: Vertex Pharmaceuticals Incorporated vs HUTCHMED (China) Limited